S Broder

13.3k total citations · 7 hit papers
96 papers, 10.8k citations indexed

About

S Broder is a scholar working on Infectious Diseases, Immunology and Virology. According to data from OpenAlex, S Broder has authored 96 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Infectious Diseases, 39 papers in Immunology and 33 papers in Virology. Recurrent topics in S Broder's work include HIV/AIDS drug development and treatment (33 papers), HIV Research and Treatment (33 papers) and T-cell and Retrovirus Studies (21 papers). S Broder is often cited by papers focused on HIV/AIDS drug development and treatment (33 papers), HIV Research and Treatment (33 papers) and T-cell and Retrovirus Studies (21 papers). S Broder collaborates with scholars based in United States, Malaysia and France. S Broder's co-authors include Hiroaki Mitsuya, Thomas A. Waldmann, Takashi Uchiyama, Dani P. Bolognesi, P A Furman, Sandra Nusinoff Lehrman, M H St Clair, Kent J. Weinhold, Robert Yarchoan and Robert C. Gallo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.

In The Last Decade

S Broder

94 papers receiving 9.9k citations

Hit Papers

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent... 1974 2026 1991 2008 1985 1986 1981 1986 1974 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.
    1985 1.5k citations Hiroaki Mitsuya, Kent J. Weinhold et al. Proceedings of the National Academy of Sciences profile →
  2. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.
    1986 1.2k citations P A Furman, James A. Fyfe et al. Proceedings of the National Academy of Sciences profile →
  3. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.
    1981 1.2k citations S Broder, Thomas A. Waldmann et al. profile →
  4. Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.
    1986 885 citations Hiroaki Mitsuya, S Broder Proceedings of the National Academy of Sciences profile →
  5. ROLE OF SUPPRESSOR T CELLS IN PATHOGENESIS OF COMMON VARIABLE HYPOGAMMAGLOBULINÆMIA
    1974 594 citations Thomas A. Waldmann, S Broder et al. The Lancet profile →
  6. Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus.
    1987 444 citations Makoto Matsukura, Hiroaki Mitsuya et al. Proceedings of the National Academy of Sciences profile →
  7. The Sézary syndrome: a malignant proliferation of helper T cells.
    1976 384 citations S Broder, C K Goldman et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Broder United States 46 4.7k 4.1k 3.4k 2.7k 2.0k 96 10.8k
Samuel Broder United States 57 5.8k 1.2× 5.1k 1.2× 3.0k 0.9× 3.0k 1.1× 2.8k 1.4× 121 12.3k
Angus Dalgleish United Kingdom 63 3.4k 0.7× 6.3k 1.5× 8.1k 2.4× 5.1k 1.8× 2.6k 1.3× 363 18.4k
Robert Yarchoan United States 75 6.5k 1.4× 5.6k 1.4× 3.6k 1.1× 3.3k 1.2× 4.8k 2.5× 334 18.7k
Bijan Safai United States 35 2.1k 0.4× 3.0k 0.7× 2.8k 0.8× 832 0.3× 1.9k 0.9× 115 7.5k
Kent J. Weinhold United States 50 4.2k 0.9× 6.5k 1.6× 4.0k 1.2× 2.6k 0.9× 2.4k 1.2× 170 10.1k
Donald E. Mosier United States 56 1.7k 0.4× 3.0k 0.7× 5.7k 1.7× 2.4k 0.9× 1.4k 0.7× 157 10.3k
Dean L. Mann United States 57 1.3k 0.3× 2.1k 0.5× 5.1k 1.5× 2.2k 0.8× 1.4k 0.7× 185 10.1k
J. Steven McDougal United States 41 3.6k 0.8× 5.9k 1.4× 3.8k 1.1× 1.5k 0.5× 2.2k 1.1× 87 9.4k
David Kabat United States 57 2.4k 0.5× 4.7k 1.2× 3.9k 1.1× 4.9k 1.8× 1.6k 0.8× 151 11.5k
John Ghrayeb United States 36 2.2k 0.5× 4.5k 1.1× 4.7k 1.4× 2.4k 0.9× 2.9k 1.5× 58 11.2k

Countries citing papers authored by S Broder

Since Specialization
Citations

This map shows the geographic impact of S Broder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Broder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Broder more than expected).

Fields of papers citing papers by S Broder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Broder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Broder. The network helps show where S Broder may publish in the future.

Co-authorship network of co-authors of S Broder

This figure shows the co-authorship network connecting the top 25 collaborators of S Broder. A scholar is included among the top collaborators of S Broder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Broder. S Broder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pluda, James M., Andrea Foli, M. Wayne Saville, et al.. (1995). Phase I/II study of intermittent all-trans-retinoic acid, alone and in combination with interferon alfa-2a, in patients with epidemic Kaposi's sarcoma.. Journal of Clinical Oncology. 13(8). 1966–1974. 40 indexed citations
2.
Yarchoan, Robert, Jill Lietzau, Otis W. Brawley, et al.. (1994). A Randomized Pilot Study of Alternating or Simultaneous Zidovudine and Didanosine Therapy in Patients with Symptomatic Human Immunodeficiency Virus Infection. The Journal of Infectious Diseases. 169(1). 9–17. 64 indexed citations
3.
Gao, Wen, T Shirasaka, David G. Johns, S Broder, & Hiroaki Mitsuya. (1993). Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells.. Journal of Clinical Investigation. 91(5). 2326–2333. 203 indexed citations
4.
Pluda, James M., Andrea Foli, Steven R. Tannenbaum, et al.. (1993). Administration of Pentosan Polysulfate to Patients With Human Immunodeficiency Virus-Associated Kaposi's Sarcoma. JNCI Journal of the National Cancer Institute. 85(19). 1585–1592. 48 indexed citations
5.
Broder, S. (1992). From the National Institutes of Health. JAMA. 267(14). 1892–1892. 98 indexed citations
6.
7.
Hayashi, Seiji, Robert L. Fine, Ting‐Chao Chou, et al.. (1990). In vitro inhibition of the infectivity and replication of human immunodeficiency virus type 1 by combination of antiretroviral 2',3'-dideoxynucleosides and virus-binding inhibitors. Antimicrobial Agents and Chemotherapy. 34(1). 82–88. 39 indexed citations
8.
Perno, Carlo Federico, Michael Baseler, S Broder, & Robert Yarchoan. (1990). Infection of monocytes by human immunodeficiency virus type 1 blocked by inhibitors of CD4-gp120 binding, even in the presence of enhancing antibodies.. The Journal of Experimental Medicine. 171(4). 1043–1056. 62 indexed citations
9.
Yarchoan, Robert, James M. Pluda, Rose V. Thomas, et al.. (1990). Long-term toxicity/activity profile of 2',3'-dideoxyinosine in AIDS or AIDS-related complex. The Lancet. 336(8714). 526–529. 168 indexed citations
10.
Hayashi, Seiji, Daniel W. Norbeck, Robert L. Fine, et al.. (1990). Cyclobut-A and cyclobut-G, carbocyclic oxetanocin analogs that inhibit the replication of human immunodeficiency virus in T cells and monocytes and macrophages in vitro. Antimicrobial Agents and Chemotherapy. 34(2). 287–294. 66 indexed citations
11.
Mori, Kazuyo, Claudine Boiziau, C. Cazenave, et al.. (1989). Phosphoroselenoate oligodeoxynucleotides: synthesis, physico-chemical characterization, anti-sense inhibitory properties and anti-HIV activity. Nucleic Acids Research. 17(20). 8207–8219. 58 indexed citations
12.
Brunetti, Arturo, Gerrit van den Berg, Giovanni Di Chiro, et al.. (1989). Reversal of brain metabolic abnormalities following treatment of AIDS dementia complex with 3'-azido-2',3'-dideoxythymidine (AZT, zidovudine): a PET-FDG study.. PubMed. 30(5). 581–90. 48 indexed citations
13.
Hayashi, Seiji, et al.. (1988). Adenallene and cytallene: acyclic-nucleoside analogues that inhibit replication and cytopathic effect of human immunodeficiency virus in vitro.. Proceedings of the National Academy of Sciences. 85(16). 6127–6131. 58 indexed citations
14.
Balzarini, Jan, David A. Cooney, Maha Dalal, et al.. (1987). 2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis.. Molecular Pharmacology. 32(6). 798–806. 65 indexed citations
15.
Furman, P A, James A. Fyfe, M H St Clair, et al.. (1986). Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.. Proceedings of the National Academy of Sciences. 83(21). 8333–8337. 1167 indexed citations breakdown →
16.
Mitsuya, Hiroaki & S Broder. (1986). Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.. Proceedings of the National Academy of Sciences. 83(6). 1911–1915. 885 indexed citations breakdown →
17.
Mitsuya, Hiroaki, Ruth F. Jarrett, Jeffrey Cossman, et al.. (1986). Infection of human T lymphotropic virus-I-specific immune T cell clones by human T lymphotropic virus-I.. Journal of Clinical Investigation. 78(5). 1302–1310. 13 indexed citations
18.
Whang‐Peng, J., Bunn Pa, Turid Knutsen, et al.. (1985). Cytogenetic Studies in Human T-cell Lymphoma Virus (HTLV)-Positive Leukemia-Lymphoma in the United States. JNCI Journal of the National Cancer Institute. 74(2). 357–69. 38 indexed citations
19.
Waldmann, Thomas A., et al.. (1983). Disorders of B cells and helper T cells in the pathogenesis of the immunoglobulin deficiency of patients with ataxia telangiectasia.. Journal of Clinical Investigation. 71(2). 282–295. 70 indexed citations
20.
Broder, S, Dean L. Mann, & Thomas A. Waldmann. (1980). Participation of suppressor T cells in the immunosuppressive activity of a heteroantiserum to human Ia-like antigens (p23,30).. The Journal of Experimental Medicine. 151(1). 257–262. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samuel Broder Breakdown of academic impact, for papers by Angus Dalgleish Breakdown of academic impact, for papers by Robert Yarchoan Breakdown of academic impact, for papers by Bijan Safai Breakdown of academic impact, for papers by Kent J. Weinhold Breakdown of academic impact, for papers by Donald E. Mosier Breakdown of academic impact, for papers by Dean L. Mann Breakdown of academic impact, for papers by J. Steven McDougal Breakdown of academic impact, for papers by David Kabat Breakdown of academic impact, for papers by John Ghrayeb
Rankless by CCL
2026